Oral Corticosteroid Use During Pregnancy and the Risk of Gestational Diabetes
In this cohort study, OCS exposure during pregnancy was not associated with an increased risk of gestational diabetes, except for a modest increase in risk among women exposed to OCSs between 4 and 6 weeks' gestation, supporting the use of OCSs when clinically indicated.
Authors
- Eun‐Young Choi (ORCID: https://orcid.org/0000-0003-4208-791X)
- Yongtai Cho (ORCID: https://orcid.org/0000-0003-3303-7881)
- Hoon Kim (ORCID: https://orcid.org/0000-0002-5623-6368)
- Ahhyung Choi
- Ju‐Young Shin (ORCID: https://orcid.org/0000-0002-2791-1037)
- J. Oh (ORCID: https://orcid.org/0009-0000-6779-0957)
Institutions
- Seoul National University (KR)
- Samsung (South Korea) (KR)
- Seoul National University Hospital (KR)
- Karolinska Institutet (SE)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- JAMA Internal Medicine
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1001/jamainternmed.2025.6367
- Primary Topic
- Gestational Diabetes Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00